Monday, January 26, 2015 Last update: 7:03 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Celsion Corporation

News articles for Celsion Corporation:

Tuesday, January 20, 2015

Tuesday, January 6, 2015

Wednesday, November 5, 2014

Tuesday, November 4, 2014

Wednesday, October 29, 2014

Tuesday, October 7, 2014

Monday, September 8, 2014

Thursday, September 4, 2014

Tuesday, September 2, 2014

Thursday, August 28, 2014

  • Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference
    LAWRENCEVILLE, N.J., Aug. 28, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that Michael H. Tardugno, Celsion's President and Chief Executive Officer, will be presenting at the Rodman & Renshaw 16th Annual Healthcare Conference on Tuesday, September 9(,), 2014 at ... read more

Thursday, August 7, 2014

  • Celsion Corporation Reports Second Quarter 2014 Financial Results
    LAWRENCEVILLE, N.J., Aug. 7, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the second quarter ended June 30, 2014. The Company also provided an update on its development programs for ThermoDox(®), its proprietary heat-activated liposomal encapsulation ... read more

Thursday, July 31, 2014

  • Celsion Corporation to Hold Second Quarter 2014 Financial Results
    LAWRENCEVILLE, N.J., July 31, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss its second quarter 2014 financial results at 11:00 a.m. EDT on Thursday, August 7, 2014. To participate in the call, interested parties may ... read more

Monday, November 12, 2012

  • Celsion Corporation Reports Third Quarter 2012 Financial Results and Business Update
    LAWRENCEVILLE, NJ -- (Marketwire) -- 11/12/12 -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced financial results for the third quarter ended September 30, 2012 and provided a business update including development progress with ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin for the treatment ... read more

Friday, November 9, 2012

Tuesday, November 6, 2012

Friday, November 2, 2012

Monday, October 1, 2012

Tuesday, September 18, 2012

Friday, September 14, 2012